![Francis O'Donnell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Francis O'Donnell
Directeur Général chez
HEDGEPATH PHARMACEUTICALS INC
Fortune : 13 350 $ au 31/08/2026
Profil
Francis E.
O'Donnell is the founder of Hopkins Capital Group, founded in 1999, serving as Chief Executive Officer.
Dr. O'Donnell was the founder of BioDelivery Sciences International, Inc., founded in 2000, serving as Director from 2018 to 2020.
Dr. O'Donnell was also the founder of Biotech Specialty Partners LLC,Repurposed Therapeutics, Inc.,RetinaPharma Technologies, Inc.,Laser Vision Centers, Inc...
Dr. O'Donnell was Executive Chairman & Chief Executive Officer at Inhibitor Therapeutics, Inc. since 2022.
Dr. O'Donnell is Chairman at PhotoVision Pharmaceuticals, Inc. Dr. O'Donnell is Chairman at Defender Pharmaceuticals, Inc. Dr. O'Donnell is Trustee at Health Careers Foundation.
Former positions include Chairman & Chief Executive Officer at Accentia Biopharmaceuticals, Inc. from 2002 to 2012; Executive Chairman at BioVest International, Inc. from 2012 to 2013; Executive Chairman at Inhibitor Therapeutics, Inc. from 2013 to 2016; Chairman-Ophthalmology Department at Saint Louis University School of Medicine; Trustee at St. Louis University.
Education includes undergraduate studies at The Johns Hopkins University School of Medicine.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 17/08/2026 | 150 000 ( 0,09% ) | 13 350 $ | 31/08/2026 |
Postes actifs de Francis O'Donnell
| Sociétés | Poste | Début |
|---|---|---|
| HEDGEPATH PHARMACEUTICALS INC | Directeur Général | 13/12/2022 |
Hopkins Capital Group
 Hopkins Capital Group Investment ManagersFinance Hopkins Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Directeur Général | 01/01/1999 |
Health Careers Foundation | Directeur/Membre du Conseil | - |
PhotoVision Pharmaceuticals, Inc.
 PhotoVision Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides life sciences technology services | Président | 08/06/2010 |
Defender Pharmaceuticals, Inc.
 Defender Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of pharmaceuticals | Président | - |
Anciens postes connus de Francis O'Donnell
| Sociétés | Poste | Fin |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Directeur Général | 22/08/2005 |
| HEDGEPATH PHARMACEUTICALS INC | Président | 22/11/2016 |
BioVest International, Inc.
 BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Président | 01/03/2013 |
Laser Vision Centers, Inc.
 Laser Vision Centers, Inc. Finance/Rental/LeasingFinance Provides excimer lasers and services to eye surgeons | Fondateur | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ | - |
Formation de Francis O'Donnell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
48
Relations au 1er degré
15
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 15 |
|---|---|
Laser Vision Centers, Inc.
Laser Vision Centers, Inc. Finance/Rental/LeasingFinance Provides excimer lasers and services to eye surgeons | Finance |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
BioVest International, Inc.
BioVest International, Inc. Medical SpecialtiesHealth Technology Develops and commercializes personalized therapeutic cancer vaccine for the treatment of B-cell blood cancers | Health Technology |
Accentia Biopharmaceuticals, Inc.
 Accentia Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets biopharmaceuticals | Health Technology |
St. Louis University
 St. Louis University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
RetinaPharma Technologies, Inc.
 RetinaPharma Technologies, Inc. Medical DistributorsDistribution Services Develops products for the prevention, treatment, and diagnosis | Distribution Services |
Health Careers Foundation | |
Biotech Specialty Partners LLC
 Biotech Specialty Partners LLC Pharmaceuticals: MajorHealth Technology Speciality in pharmacy & biotechology | Health Technology |
PhotoVision Pharmaceuticals, Inc.
PhotoVision Pharmaceuticals, Inc. Miscellaneous Commercial ServicesCommercial Services Provides life sciences technology services | Commercial Services |
Hopkins Capital Group
Hopkins Capital Group Investment ManagersFinance Hopkins Capital invests in companies located in the United States. The firm focuses on a broad range of sectors and industries. It provides financing for buyout transactions. | Finance |
Inhibitor Therapeutics, Inc.
 Inhibitor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
The Johns Hopkins University School of Medicine
 The Johns Hopkins University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saint Louis University School of Medicine
 Saint Louis University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Repurposed Therapeutics, Inc. | |
Defender Pharmaceuticals, Inc.
Defender Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Engages in the discovery, development and commercialization of pharmaceuticals | Health Technology |
